Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Proestel

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|March 14, 2008
Subgroup analyses in clinical trialsScott Proestel
Drug Safety|September 15, 2025
The Development and Use of Office of New Drugs Custom Medical Queries for Safety Analyses of Clinical Trial DataScott Proestel, Vaishali Popat, Ellis F Unger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2013
Ensuring participant safety and trial integrity with clinical trials oversightCatherine Godfrey, Manizhe Payton, Sybil Tasker, et al.
Journal of the American Medical Informatics Association : JAMIA|April 4, 2017
Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting systemLichy Han, Robert Ball, Carol A Pamer, et al.
Therapeutic Innovation & Regulatory Science|June 14, 2025
Semantic Search of FDA Guidance Documents Using Generative AIScott Proestel, Linda J B Jeng, Christopher Smith, et al.
Therapeutic Innovation & Regulatory Science|August 8, 2022
MedDRA Labeling Groupings to Improve Safety Communication in Product LabelsIlona Große-Michaelis, Scott Proestel, Radhika M Rao, et al.
Drug Safety|January 4, 2017
Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety AlertsCarrie E Pierce, Khaled Bouri, Carol Pamer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|March 14, 2008
Subgroup analyses in clinical trialsScott Proestel
Drug Safety|September 15, 2025
The Development and Use of Office of New Drugs Custom Medical Queries for Safety Analyses of Clinical Trial DataScott Proestel, Vaishali Popat, Ellis F Unger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 11, 2013
Ensuring participant safety and trial integrity with clinical trials oversightCatherine Godfrey, Manizhe Payton, Sybil Tasker, et al.
Journal of the American Medical Informatics Association : JAMIA|April 4, 2017
Development of an automated assessment tool for MedWatch reports in the FDA adverse event reporting systemLichy Han, Robert Ball, Carol A Pamer, et al.
Therapeutic Innovation & Regulatory Science|June 14, 2025
Semantic Search of FDA Guidance Documents Using Generative AIScott Proestel, Linda J B Jeng, Christopher Smith, et al.
Therapeutic Innovation & Regulatory Science|August 8, 2022
MedDRA Labeling Groupings to Improve Safety Communication in Product LabelsIlona Große-Michaelis, Scott Proestel, Radhika M Rao, et al.
Drug Safety|January 4, 2017
Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety AlertsCarrie E Pierce, Khaled Bouri, Carol Pamer, et al.
Pageof 1